Loading...
Last submissions
-
Pauline Marolleau, David Tougeron, Benoit Allignet, Romain Cohen, David Sefrioui, et al.. Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. International Journal of Cancer, 2023, ⟨10.1002/ijc.34636⟩. ⟨hal-04154476⟩
-
Feredun Azari, Ruben P J Meijer, Gregory T Kennedy, Andrew Hanna, Ashley Chang, et al.. Carcinoembryonic Antigen–Related Cell Adhesion Molecule Type 5 Receptor–Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer. JAMA Network Open, 2023, 6 (1), pp.e2252885. ⟨10.1001/jamanetworkopen.2022.52885⟩. ⟨hal-04588970⟩
-
Victor Sérénon, Philippe Rouanet, Diane Charleux-Muller, Clarisse Eveno, Karine Poirot, et al.. Iatrogenic ureteral injury during colorectal surgery has a significant impact on patient outcomes: a French multicentric retrospective cohort study. Colorectal Disease, 2023, ⟨10.1111/codi.16630⟩. ⟨hal-04113776⟩
-
Thierry André, David Tougeron, Guillaume Piessen, Christelle de La Fouchardière, Christophe Louvet, et al.. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. Journal of Clinical Oncology, 2023, 41 (2), pp.255-265. ⟨10.1200/JCO.22.00686⟩. ⟨hal-03975142⟩
-
Sara A Hurvitz, Roberto Hegg, Wei-Pang Chung, Seock-Ah Im, William Jacot, et al.. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial. The Lancet, 2023, 401 (10371), pp.105-117. ⟨10.1016/s0140-6736(22)02420-5⟩. ⟨hal-04581303⟩
-
Aurelien Flattres, Yassir Aarab, Stephanie Nougaret, Fanny Garnier, R. Larcher, et al.. Real-time shear wave ultrasound elastography: a new tool for the evaluation of diaphragm and limb muscle stiffness in critically ill patients. Critical Care, 2020, 24 (1), pp.34. ⟨10.1186/s13054-020-2745-6⟩. ⟨hal-02468739v2⟩
-
Elodie Simphor, Anne Rognon, Emmanuel Vignal, Sylvain Henry, Jean-François Allienne, et al.. Combining a transcriptomic approach and a targeted metabolomics approach for deciphering the molecular bases of compatibility phenotype in the snail Biomphalaria glabrata toward Schistosoma mansoni.. Acta Tropica, In press, ⟨10.1016/j.actatropica.2024.107212⟩. ⟨hal-04555554⟩
-
Léa Rubira, Charlotte Donzé, Juliette Fouillet, Benjamin Algudo, Pierre Olivier Kotzki, et al.. [68Ga]Ga-FAPI-46 synthesis on a GAIA® module system: thorough study of the automated radiolabeling reaction conditions. Applied Radiation and Isotopes, 2024, 206, pp.111211. ⟨10.1016/j.apradiso.2024.111211⟩. ⟨hal-04544439⟩
-
Jessica Andries, Wildriss Viranaicken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, et al.. Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech). Scientific Reports, 2022, 12 (1), ⟨10.1038/s41598-022-10885-7⟩. ⟨hal-04542363⟩